Ignite Creation Date:
2024-05-06 @ 7:40 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06090266
Status:
RECRUITING
Last Update Posted:
2023-11-02
First Post:
2023-09-29
Brief Title:
A Study of OR502 a Monoclonal Antibody Targeting LILRB2 Alone and in Combination With Anticancer Agents
Sponsor:
OncoResponse Inc
Organization:
OncoResponse Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Cutaneous Squamous Cell Carcinoma |
| Cancer |
| Tumor Solid |
| Malignant Neoplasm |
| Metastatic Cancer |
| Advanced Solid Tumor |
| Platinum-resistant Ovarian Cancer |
Keywords: